期刊文献+

喹硫平与锂盐治疗双相障碍急性躁狂效果对比 被引量:3

下载PDF
导出
摘要 目的:探讨双相障碍急性躁狂采用喹硫平与锂盐治疗效果对比。方法:选取2011年7月到2012年7月来本院接受双相障碍急性躁狂治疗的病患104例,将其进行随机分组,分别为喹硫平组52例和锂盐组52例,比较效果及不良反应。结果:与锂盐组比较,喹硫平组在治疗后4周内PANSS评分、YMRS评分、MADRS评分下降幅度均呈较高水平,其中YMRS、PANSS与锂盐组比较有明显差异(P<0.05)。喹硫平组恶心率低于锂盐组(P<0.05),便秘率高于锂盐组(P<0.05),腹泻、呕吐率无明显差异(P>0.05)。结论:与锂盐比较,喹硫平对双相障碍急性躁狂的治疗更加安全有效。
机构地区 徐州精神病院
出处 《中国民康医学》 2013年第19期44-45,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献5

二级参考文献44

  • 1黄文升,邸晓兰,杨甫德,牛亚娟,吉中孚,王向群.现代电休克治疗激越行为对照研究[J].临床精神医学杂志,2004,14(5):276-277. 被引量:57
  • 2Vieta E, Mullen J, Brecher M, et al. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Curr Med Res Opin, 2005, 21:923-934.
  • 3Sachs G, Chengappa KN, Suppes T, et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord, 2004, 6:213-223.
  • 4American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry, 2002, 159 (4 Suppl) : 1-50.
  • 5Bowden CL, Grunze H, Mullen J, et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry, 2005, 66 : 111-121.
  • 6Mclntyre RS, Brecher M, Paulsson B, et al. Quetiapine or haloperidol as monotherapy for bipolar mania: a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol, 2005, 15:573-585.
  • 7Ketter TA, Jones M, Paulsson B. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania. J Affect Disord, 2007, 100 Suppl 1 :S45-53.
  • 8Brahm NC, Gutierres SL, Carnahan RM. Quetiapine for acute mania in bipolar disorder. Am J Health Syst Pharm, 2007, 64: 1045-1053.
  • 9Miodownik C, Lerner V. Quetiapine : efficacy, tolerability and safety in schizophrenia. Expert Rev Neurother, 2006, 6:983-992.
  • 10Vieta E, Mullen J, Brecher M, et al. Quetiapine monotherapy for mania associated with bipolar disorder; combined analysis of two international, double - blind, randomized, placebo - controlled studies[J]. Curr Med Res Opin, 2005, 21:923 -934.

共引文献24

同被引文献33

  • 1中华医学会精神科分会.中国精神障碍分类与诊断标准[M].济南:山东科学技术出版社,2001.75-90.
  • 2Kar agianis JL, Dawe IC, Thakur A, et al. Rapid tranqui- lization wit h olanzapine in acute psychosis: A ease series [J]. J Clin Psychiatry, 2011, 62 (13) : 12-16.
  • 3Vieta E, MuUen J, Breeher M, et al. Quatrain immunotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomized, placebo controlled studies[J]. Curt Med Resopin, 2005, 21 (6) : 923-934.
  • 4Baker RW, Kinon B J, Maguire GA, et al. Effective of rapid initial dose E escalation of up to forty milligrams per day of oral olanzapine in a cute agitation [J]. J Clin Psychopharmaco, 2013, 23 (4) : 342-348.
  • 5Beasly CM, Hamilton SH, Crawford AM, et al. Olanzanpine versus haloperidol: acute phase results of the international double blind Olanzanpine trial [J]. Eur Psychopharmacology, 2011, 7 (13) : 125-137.
  • 6Sachs G, Chengappa KNR, Suppes T, et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study [J]. Biploar Disorder, 2012, 6 (3) : 213-223.
  • 7王志广,沈秀梅,韦有芳,王晓枫,梁兆霞.奥氮平合并碳酸锂治疗躁狂发作临床对照研究[J].精神医学杂志,2007,20(6):373-374. 被引量:7
  • 8陈振林,孙祥生,夏友春,于海鹏,陆燕.奎硫平联合抗抑郁剂在双相抑郁中的应用[J].临床精神医学杂志,2011,21(5):325-325. 被引量:12
  • 9蒋玉龙,吴志国,粟幼嵩,易正辉,王祖承,卢卫红.碳酸锂合并喹硫平治疗双相障碍抑郁发作的疗效和安全性研究[J].中国医药导报,2012,9(2):86-88. 被引量:20
  • 10司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,孙立忠,师建国,陈宪生,梅其一,栗克清.2006年我国十省市双相障碍患者药物使用的横断面调查[J].中华精神科杂志,2012,45(1):29-34. 被引量:11

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部